In univariate analysis, using the log rank test, larger tumor size (p = 0.0004), nodal involvement (p = 0.0036), SBR grade (p = 0.0028), lack of estrogen and progesterone receptor expression (p = 0.0123 and 0.0132 respectively), CCR6 expression (p = 0.0316)(Figure 2A) and infiltration by CCL19/MIP3β-expressing DC (p = 0.0417)(Figure 2B) were associated with shorter relapse-free survival (RFS). The gene discussed is CCR6; the disease is neoplasm.